ENvue Medical (FEED) Shares Outstanding (2014 - 2026)
ENvue Medical's (FEED) quarterly Shares Outstanding (Entity) came in at $513104.0 in Q2 2026, up 1170.69% year-over-year from $40380.0 in Q2 2025, and up 66.37% quarter-over-quarter from $308409.0 in Q1 2026.
Powered by 
Analysis
ENvue Medical (FEED) Shares Outstanding (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Shares Outstanding (Entity) for 13 consecutive years, with $513104.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 1170.69% year-over-year to $513104.0 in Q2 2026; TTM through Jun 2026 was $513104.0, a 1170.69% increase from a year earlier, with the FY2025 full-year figure at $52378.0, up 2228.95% from the prior year.
- Shares Outstanding (Entity) was $513104.0 for Q2 2026 at ENvue Medical, up from $308409.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $513104.0 in Q2 2026 and troughed at $1061.0 in Q1 2022.
- A 5-year average of $56839.5 and a median of $2109.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) increased 3.11% in 2022 and surged 4941.83% in 2026, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $1243.0 in 2022, then rose by 24.7% to $1550.0 in 2023, then surged by 45.1% to $2249.0 in 2024, then surged by 2228.95% to $52378.0 in 2025, then soared by 879.62% to $513104.0 in 2026.
- The last three Shares Outstanding (Entity) figures came in at $513104.0 (Q2 2026), $308409.0 (Q1 2026), and $52378.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 97.60 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | 513,104.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 513,104.00 |
| Mar 31, 2026 | 274,087.00 |
| Dec 31, 2025 | 52,378.00 |
| Sep 30, 2025 | 71,536.00 |
| Jun 30, 2025 | 40,380.00 |
| Mar 31, 2025 | 5,218.00 |
| Dec 31, 2024 | 2,249.00 |
| Sep 30, 2024 | 2,124.00 |
| Jun 30, 2024 | 2,109.00 |
| Mar 31, 2024 | 1,902.00 |
| Dec 31, 2023 | 1,326.00 |
| Sep 30, 2023 | 1,304.00 |
| Jun 30, 2023 | 1,259.00 |
| Mar 31, 2023 | 1,251.00 |
| Dec 31, 2022 | 1,076.00 |
| Sep 30, 2022 | 1,061.00 |
| Jun 30, 2022 | 1,061.00 |
| Mar 31, 2022 | 1,061.00 |
| Dec 31, 2021 | 953.00 |
| Sep 30, 2021 | 989.00 |